BACKGROUND: Sepsis is the most frequent infection with high mortality rates in intensive care units (ICUs), and the prediction of outcome is important in the decision-making process. OBJECTIVE: To assess the value of the Acute Physiology and Chronic Health Evaluation II (APACHE II) and indocyanin green (ICG) plasma disappearance rate (ICG-PDR) in septic patients. DESIGN: Retrospective analysis. MEASUREMENTS AND RESULTS: We analyzed 40 septic patients (17 female and 23 male; age range, 20-89 years) who were treated in our ICU. The ICG-PDR measurement and APACHE II score measurement were made within 24 hours after admission to the ICU. Indocyanine green elimination tests were conducted concurrently using the noninvasive liver function monitoring system (LiMON, Pulsion Medical Systems, Munich, Germany). A dose of 0.3 mg/kg ICG was given through a cubital fossa vein as a bolus. RESULTS: Statistical analysis showed that ICG-PDR was significantly lower in nonsurvivors (n = 18) than in survivors (n = 22) (mean, 12.1% +/- 7.6%/min; median, 9%/min, vs mean, 21.2% +/- 10.1%/min; median, 20%/min, respectively [P = .004]). The area under the curve as a measure of accuracy was 0.765 for ICG-PDR and 0.692 for APACHE II. Mortality was 80% in patients with ICG-PDR below 8% per minute, and survival was approximately 89% in patients with ICG-PDR above 24% per minute. CONCLUSION: The results suggest that ICG-PDR, assessed with a user-friendly noninvasive bedside LiMON device, is a good predictor of survival in septic patients. Sensitivity and specificity of the noninvasive measurement of ICG-PDR on ICU admission was comparable to that obtained by APACHE II scores.
BACKGROUND: Sepsis is the most frequent infection with high mortality rates in intensive care units (ICUs), and the prediction of outcome is important in the decision-making process. OBJECTIVE: To assess the value of the Acute Physiology and Chronic Health Evaluation II (APACHE II) and indocyanin green (ICG) plasma disappearance rate (ICG-PDR) in septic patients. DESIGN: Retrospective analysis. MEASUREMENTS AND RESULTS: We analyzed 40 septic patients (17 female and 23 male; age range, 20-89 years) who were treated in our ICU. The ICG-PDR measurement and APACHE II score measurement were made within 24 hours after admission to the ICU. Indocyanine green elimination tests were conducted concurrently using the noninvasive liver function monitoring system (LiMON, Pulsion Medical Systems, Munich, Germany). A dose of 0.3 mg/kg ICG was given through a cubital fossa vein as a bolus. RESULTS: Statistical analysis showed that ICG-PDR was significantly lower in nonsurvivors (n = 18) than in survivors (n = 22) (mean, 12.1% +/- 7.6%/min; median, 9%/min, vs mean, 21.2% +/- 10.1%/min; median, 20%/min, respectively [P = .004]). The area under the curve as a measure of accuracy was 0.765 for ICG-PDR and 0.692 for APACHE II. Mortality was 80% in patients with ICG-PDR below 8% per minute, and survival was approximately 89% in patients with ICG-PDR above 24% per minute. CONCLUSION: The results suggest that ICG-PDR, assessed with a user-friendly noninvasive bedside LiMON device, is a good predictor of survival in septic patients. Sensitivity and specificity of the noninvasive measurement of ICG-PDR on ICU admission was comparable to that obtained by APACHE II scores.
Authors: Mehmet Turan Inal; Dilek Memis; Y Atakan Sezer; Meltem Atalay; Abdullah Karakoc; Necdet Sut Journal: Can J Surg Date: 2011-06 Impact factor: 2.089
Authors: S A Kaulen; C Hübner; J Mieth; K Spindler; R Schwab; R Wimmer; J Wilhelm; M Amoury; M Girndt; K Werdan; H Ebelt Journal: Med Klin Intensivmed Notfmed Date: 2014-09-03 Impact factor: 0.840
Authors: Magnus F Kaffarnik; Johan F Lock; Hannah Vetter; Navid Ahmadi; Christian Lojewski; Maciej Malinowski; Peter Neuhaus; Martin Stockmann Journal: Crit Care Date: 2013-10-31 Impact factor: 9.097
Authors: Guowei Li; Lehana Thabane; Deborah J Cook; Renato D Lopes; John C Marshall; Gordon Guyatt; Anne Holbrook; Noori Akhtar-Danesh; Robert A Fowler; Neill K J Adhikari; Rob Taylor; Yaseen M Arabi; Dean Chittock; Peter Dodek; Andreas P Freitag; Stephen D Walter; Diane Heels-Ansdell; Mitchell A H Levine Journal: Ann Intensive Care Date: 2016-02-27 Impact factor: 6.925
Authors: Ulrich Mayr; Leonie Fahrenkrog-Petersen; Gonzalo Batres-Baires; Alexander Herner; Sebastian Rasch; Roland M Schmid; Wolfgang Huber; Tobias Lahmer Journal: Ann Intensive Care Date: 2018-07-06 Impact factor: 6.925
Authors: Glenn Hernandez; Tomas Regueira; Alejandro Bruhn; Ricardo Castro; Maximiliano Rovegno; Andrea Fuentealba; Enrique Veas; Dolores Berrutti; Jorge Florez; Eduardo Kattan; Celeste Martin; Can Ince Journal: Ann Intensive Care Date: 2012-10-15 Impact factor: 6.925
Authors: Manu Lng Malbrain; Dries Viaene; Andreas Kortgen; Inneke De Laet; Hilde Dits; Niels Van Regenmortel; Karen Schoonheydt; Michael Bauer Journal: Ann Intensive Care Date: 2012-12-20 Impact factor: 6.925